Feedback / Questions
ifenprodil (NP-120) - Seyltx
https://www.globenewswire.com/news-release/2024/07/16/2913649/0/en/Seyltx-Announces-Positive-Pre-Clinical-Dose-Ranging-Data-with-Its-Selective-Oral-Small-Molecule-Inhibitor-of-GluN2B-Illustrating-Near-Complete-Suppression-of-Refractory-Chronic-Cou.html
Jul 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next